Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis

Bibliography

• Sanders DR, Kraff M. Steroidal and nonsteroidal anti-inflammatory agents: effect on postsurgical inflammation and blood-aqueous humor barrier breakdown. Arch Ophthalmol 1984;102:1453-6
   PubMed Web of Science ®Google Scholar
• Ferguson VMG, Spalton DJ. Recovery of the blood-aqueous barrier after cataract surgery. Br J Ophthalmol 1991;75:106-10
   PubMed Web of Science ®Google Scholar
• Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477-80
   PubMed Web of Science ®Google Scholar
• Tan DT, Chee SP, Lim L, Lim AS. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation. Ophthalmology 1999;106:223-31
   PubMed Web of Science ®Google Scholar
• Chang DF, Garcia IH, Hunkeler JD, Minas T. Phase II results of an intraocular steroid delivery system for cataract surgery. Ophthalmology 1999;106:1172-7
   PubMed Web of Science ®Google Scholar
• Tan DTH, Chee SP, Lim L, Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye. Ophthalmology 2001;108:2172-81
   PubMed Web of Science ®Google Scholar
• Wadood AC, Armbrecht AM, Aspinall PA, Dhillon B. Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsification. J Cataract Refract Surg 2004;30:761-8
   PubMed Web of Science ®Google Scholar
• Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995;120:55-64
   PubMed Web of Science ®Google Scholar
• Zamir E, Read RW, Smith RE, A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis. Ophthalmology 2002;109:798-805
   PubMed Web of Science ®Google Scholar
• Dafflon ML, Tran VT, Guex-Crosier Y, Herbort CP. Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects. Graefes Arch Clin Exp Ophthalmol 1999;237:289-95
   PubMed Web of Science ®Google Scholar
• Stern AL, Taylor DM, Dalburg LA, Cosentino RT. Pseudophakic cystoid maculopathy: a study of 50 cases. Ophthalmology 1981;88:942-6
   PubMed Web of Science ®Google Scholar
• Suckling RD, Maslin KF. Pseudophakic cystoid macular oedema and its treatment with local steroids. Aust NZ J Ophthalmol 1988;16:353-9
   PubMedGoogle Scholar
• Thach AB, Dugel PU, Flindall RJ, A comparison of retrobulbar versus sub-Tenon's corticosteroid therapy for cystoid macular edema refractory to topical medications. Ophthalmology 1997;104:2003-8
   PubMed Web of Science ®Google Scholar
• Yoshikawa K, Kotake S, Ichiishi A, Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema. Jpn J Ophthalmol 1995;39:71-6
   PubMed Web of Science ®Google Scholar
• Walton RC, Vick VL, Greenwald MA. Sub-Tenon's corticosteroid for the treatment of macular edema in bone marrow transplant retinopathy. Retina 1999;19:171-3
   PubMed Web of Science ®Google Scholar
• Cardillo JA, Melo LA Jr, Costa RA, Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2005;112:1557-63
   PubMed Web of Science ®Google Scholar
• Paganelli F, Cardillo JA, Melo LAS Jr, Brazilian Ocular Pharmacology and Pharmaceutical Technology Research Group. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation. Ophthalmology 2004;111:2102-8
   PubMed Web of Science ®Google Scholar
• Negi AK, Browning AC, Vernon SA. Single perioperative triamcinolone injection versus standard post-operative steroid drops after uneventful phacoemulsification surgery: randomized controlled trial. J Cataract Refract Surg 2006;32:468-74
   PubMed Web of Science ®Google Scholar
• West ES, Behrens A, McDonnell PJ, The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology 2005;112:1388-94
   PubMed Web of Science ®Google Scholar
• Taban M, Behrens A, Newcomb RL, Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol 2005;123:613-20
   PubMed Web of Science ®Google Scholar
• Barry P, Seal DV, Gettinby G, ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of post-operative endophthalmitis after cataract surgery. Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006;32:407-10
   PubMed Web of Science ®Google Scholar
• Behrens-Baumann W, Martell J. Ciprofloxacin concentration in the rabbit aqueous humor and vitreous following intravenous and subconjunctival administration. Infection 1988;16:54-7
   PubMed Web of Science ®Google Scholar
• Barza M. Antibacterial agents in the treatment of ocular infections. Infect Dis Clin North Am 1989;3:533-51
   PubMedGoogle Scholar
• Geroski DH, Edelhauser HF. Transscleral drug delivery for posterior segment disease. Adv Drug Deliv Rev 2001;52:37-48
   PubMed Web of Science ®Google Scholar
• Starr MB, Lally JM. Antimicrobial prophylaxis for ophthalmic surgery. Surv Ophthalmol 1995;39:485-501
   PubMed Web of Science ®Google Scholar
• Clements DB, Tailor V. A study of aqueous and serum levels of ceftazidine following subconjunctival administration. Br J Ophthalmol 1987;71:433-5
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci 1998;87:1479-88
   PubMed Web of Science ®Google Scholar
• Lehmann OJ, Roberts CJ, Ikram K, Association between nonadministration of subconjunctival cefuroxine and post-operative endophthalmitis. J Cataract Refract Surgery 1997;23:889-93
   PubMed Web of Science ®Google Scholar
• Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 2000;35:373-8
   PubMed Web of Science ®Google Scholar
• Buzard K, Liapis S. Prevention of endophthalmitis. J Cataract Refract Surgery 2004;30:1953-9
   PubMed Web of Science ®Google Scholar
• Kompella UB, Bandi N, Ayalasomayajula SP. Subconjunctival nano- and microparticles sustain retinal delivery of budesomide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Vis Sci 2003;44:1192-201
   PubMed Web of Science ®Google Scholar
• Gilbert JA, Simpson AE, Rudnick DH, Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. J Control Release 2003;89:409-17
   PubMed Web of Science ®Google Scholar
• Hosoya K, Lee VH, Kim K. Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm 2005;60:227-40
   PubMed Web of Science ®Google Scholar
• Paganelli F, Cardillo JA, Melo LA Jr, A single intraoperative sub-Tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. Invest Ophthalmol Vis Sci 2009;50:3041-7
   PubMed Web of Science ®Google Scholar
• Cardillo JA, Paganelli F, Melo LA Jr, Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery. Arch Ophthalmol 2010;128:81-7
   PubMed Web of Science ®Google Scholar
• Zeimer R, Goldberg MF. Novel ophthalmic therapeutic modalities based on noninvasive light-targeted drug delivery to the posterior pole of the eye. Adv Drug Deliv Rev 2001;52:49-61
   PubMed Web of Science ®Google Scholar
• Herrero-Vanrell R, Refojo MF. Biodegradable microspheres for vitreoretinal drug delivery. Adv Drug Deliv Rev 2001;52:5-16
   PubMed Web of Science ®Google Scholar
• Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Opthalmol Vis Sci 1995;36:1893-903
   PubMed Web of Science ®Google Scholar
• Hosoya K, Lee VHL. Cidofovir transport in pigmented rabbit conjunctiva. Curr Eye Res 1997;16:693-7
   PubMed Web of Science ®Google Scholar
• Simpson AE, Gilbert JA, Rudnick DH, Transscleral diffusion of carboplatin: an in vitro and in vivo study. Arch Ophthalmol 2002;120:1069-74
   PubMed Web of Science ®Google Scholar
• Kim SY, Yang J, Lee YC, Park YH. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery. J Cataract Refract Surg 2008;34(5):823-6
   PubMed Web of Science ®Google Scholar
• Morgan CM, Schatz H, Vine AK, Ocular complications associated with retrobulbar injections. Ophthalmology 1988;95:660-5
   PubMed Web of Science ®Google Scholar
• McLean EB. Inadvertent injection of corticosteroid into the choroidal vasculature. Am J Ophthalmol 1975;80:835-7
   PubMed Web of Science ®Google Scholar
• Ellis PP. Occlusion of the central retina artery after retrobulbar corticosteroid injection. Am J Ophthalmol 1978;85:352-6
   PubMed Web of Science ®Google Scholar
• Giles CL. Bulbar perforation during periocular injection of corticosteroids. Am J Ophthalmol 1974;77:438-41
   PubMedGoogle Scholar
• Schlaegel TF, Wilson FM. Accidental intraocular injection of depot corticosteroids. Trans Am Acad Ophthalmol Otolaryngol 1974;78:847-55
   Google Scholar
• Schechter RJ. Management of inadvertent intraocular injections. Ann Ophthalmol 1985;17:771-5
   PubMed Web of Science ®Google Scholar
• Ellis PP. Occlusion of the central retina artery after retrobulbar corticosteroid injection. Am J Ophthalmol 1978;85:352-6
   PubMed Web of Science ®Google Scholar
• Ellis PP. Retrobulbar injections. Surv Ophthalmol 1974;18:425-30
   Google Scholar
• Nozik RA. Orbital rim fat atrophy after repository periocular corticosteroid injection. Am J Ophthalmol 1976;82:928-30
   PubMed Web of Science ®Google Scholar
• O'Connor GR. Periocular corticosteroid injections: uses and abuses. Eye Ear Nose Throat Mon 1976;55:83-8
   PubMedGoogle Scholar
• Mathias CGT, Maibach HI, Ostler HB, Delayed hypersensitivity to retrobulbar injections of methylprednisolone acetate. Am J Ophthalmol 1978;86:816-9
   PubMed Web of Science ®Google Scholar
• Herschler J. Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol 1976;82:90-3
   PubMed Web of Science ®Google Scholar
• Akduman L, Kolker AE, Black DL, Treatment of persistent glaucoma secondary to periocular corticosteroids. Am J Ophthalmol 1996;122:275-7
   PubMed Web of Science ®Google Scholar
• Paccola L, Jorge R, Barbosa JC. Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. Acta Ophthalmol Scand 2007;85:603-8
   PubMedGoogle Scholar
• Homma T, Hori T, Sugimori G, Ymano Y. Pharmacodinamics assessment based on mutant prevention concentrations of fluoroquinolones to prevet the emergence of resistant mutants of Streptococcus pneumoniae. Antimicrob Agents Chemother 2007;51:3810-15
   PubMed Web of Science ®Google Scholar
• McDonald MB. Research review and update:IQUIX (levofloxacin 1.5%). Int Ophthalmol Clin 2006;46:47-60
   PubMedGoogle Scholar
• Van Bambeke F, Lambert DM, Mingeot-Leclercq MP, Tulkens PM. Chapter 188:mechanis of action. In: Cohen J, Powderly WG, editors, Infectious Diseases. 2nd edition. Mosby/Elsevier, Edinburgh, Scotland; 2004. p. 1717-32
   Google Scholar
• Bui DP, Dang SB, Hwang DG. Effect of ciprofloxacin concentration on mutation resistence rates in S.aureus. Invest Ophthalmol Vis Sci 1995;36: abstract 4876
   Web of Science ®Google Scholar
• Velpandian T. Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies. Expert Opin Drug Deliv 2009;3:255-70
   Google Scholar
• Lang LC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev 1996;16:39-45
   Web of Science ®Google Scholar
• Solomon R, Donnenfeld ED, Perry HD, Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005;112:466-9
   PubMed Web of Science ®Google Scholar
• Kim DH, Stark WJ, O'Brien TP, Dick JD. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 2005;112(11):1992-6
   PubMed Web of Science ®Google Scholar
• Price MO, Quillin C, Price FW Jr. Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration. Curr Eye Res 2005;30:563-67
   PubMed Web of Science ®Google Scholar
• Callegan MC, Ramirez R, Kane ST, Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther 2003;20:246-52
   PubMed Web of Science ®Google Scholar
• Kowalski RP, Romanowski EG, Mah FS, Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol 2004;138:33-7
   PubMed Web of Science ®Google Scholar
• Costello P, Bakri SJ, Beer PM, Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina 2006;26:191-5
   PubMed Web of Science ®Google Scholar
• Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project; for the Surgical Infection Prevention Guideline Writers Workgroup. Am J Surg 2005;189:395-404
   PubMed Web of Science ®Google Scholar
• Speaker MG, Milch FA, Shah MK, Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98:639-49
   PubMed Web of Science ®Google Scholar
• Gaal V, Kilar F, Acs B, In vitro study of antibiotic effect on bacterial adherence to acrylic intraocular lenses. Colloids Surf B Biointerfaces 2005;45:125-30
   PubMed Web of Science ®Google Scholar
• Olson RJ. Reducing the risk of postoperative endophthalmitis. Surv Opthalmol 2004;49(Suppl):S55-61
   PubMedGoogle Scholar
• Cooper BA, Holekamp NM, Bohigian G, Thompson PA. Case control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear cornea wounds. Am J Ophthalmol 2003;163:300-5
   Google Scholar
• Moshifar M, Feiz V, Vitale AT, Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones; a retrospective observational case series. Ophthalmology 2007;114:686-91
   PubMed Web of Science ®Google Scholar
• Liesegang TJ. Intracameral antibiotics: questions for the United States based on prospective studies. J Cataract Surg 2008;34:505-9
   PubMed Web of Science ®Google Scholar
• O'Brien TP, Arshinoff SA, Mah FS. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Surg 2007;33:1790-800
   PubMed Web of Science ®Google Scholar
• Vaka SR, Sammeta SM, Day LB, Murthy SN. Transcorneal iontophoresis for delivery of ciprofloxacin hydrochloride. Curr Eye Res 2008;33:661-7
   PubMed Web of Science ®Google Scholar
• Hermann MM, IOVS 2005;46: ARVO E-Abstract 3832
   Google Scholar
• Ulualp K, Condon RE. Antibiotic prophylaxis for scheduled operative procedures. Infec Dis Clin North Am 1992;6:613-25
   PubMed Web of Science ®Google Scholar